Strona główna
  • Zamawiaj do paczkomatu
  • Płać wygodnie
  • Oncofertility w praktyce klin.
  • Obniżka
The Drug Paradox: An Introduction to the Sociology of Psychoactive Substances in Canada

The Drug Paradox: An Introduction to the Sociology of Psychoactive Substances in Canada

9781773380520
379,89 zł
341,90 zł Zniżka 37,99 zł Brutto
Najniższa cena w okresie 30 dni przed promocją: 341,90 zł
Ilość
Produkt niedostępny
Chwilowy brak

  Dostawa

Wybierz Paczkomat Inpost, Orlen Paczkę, DPD, Pocztę, email (dla ebooków). Kliknij po więcej

  Płatność

Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów

  Zwroty

Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni*. Kliknij po więcej szczegółów

Opis
Why are some drugs considered socially acceptable while others are demonized? In Canada today, drugs are viewed as both beneficial and problematic, and there is no definitive agreement on what should be done to address drug use. The Drug Paradox examines both the empirically founded and socially constructed nature of drugs and drug use. In their exploration of the drug paradox, the authors discuss how the punitive approach to drug use in Canada continues to exist alongside strategies of harm reduction, though this only impedes Canada’s ability to deal effectively with substance misuse.
Szczegóły produktu
Eurospan
68430
9781773380520
9781773380520

Opis

Rok wydania
2018
Numer wydania
1
Oprawa
miękka foliowana
Liczba stron
285
Wymiary (mm)
171.00 x 248.00
  • Preface Acknowledgements Chapter 1:: The Drug Paradox:: Canada’s Conflicting Approaches to Drugs and Drug Users 1.1 What Is the Drug Paradox? 1.2 Defining the Core Concepts 1.3 The Social Reality of Drugs and Drug Use Chapter 2:: The History and Politics of Canada’s Drug Laws 2.1 Prohibition Era 2.2 The Opium Act (1908) 2.3 Proprietary or Patent Medicines Act (1908) 2.4 The Opium and Drug Act (1911) 2.5 The Opium and Narcotic Drug Act (1929) 2.6 The Narcotic Control Act (1961) 2.7 Controlled Drugs and Substances Act (1996) 2.8 Marihuana for Medical Purposes Regulations (2013) 2.9 Access to Cannabis for Medicinal Purposes Regulations (2016) 2.10 A Framework for the Legalization and Regulation of Cannabis in Canada (2016 2.11 Conclusion Chapter 3:: Explaining Substance Use I:: Biological and Psychological Theories 3.1 The Moral Model versus the Medical Model 3.2 Biological Explanations Nature and Drive Theories Genetic Theories Neurobiological Theories 3.3 Psychological Explanations Personality Theories BehaviouralTheories Psychopathology 3.4 Conclusion Chapter 4:: Explaining Substance Use II:: Sociological Theories 4.1 Control Theories Social Bonding Theory Self-Control Theory 4.2 Strain Theories Anomie/Strain Theory General Strain Theory 4.3 Subcultural Theories Labelling Theory Differential Association Theory Social Learning Theory (Differential Association-Reinforcement Theory) 4.4 Integrated Explanations of Substance Use Differential Opportunity Theory Drift Theory Routine Activities and Lifestyle Theories 4.5 Conflict Theories Marxian Conflict Theory Pluralist Conflict Theory 4.6 Postmodern Explanations Normalization Thesis Foucault and Biopower 4.7 Conclusion Chapter 5:: Classifying Drugs:: Psychopharmacological Properties and Legal Classifications 5.1 What is Psychopharmacology and Why Does It Matter to Sociologists? 5.2 Opioids (Narcotics) Natural Opioids Semi-Synthetic Opioids Synthetic Opioids Legal Classification and Penalties for Opioids 5.3 Depressants Alcohol Barbiturates Benzodiazepines Inhalants/Solvents Legal Classification and Penalties for Depressants 5.4 Stimulants Cocaine Amphetamines (including Methamphetamine) Nicotine Caffeine Legal Classification and Penalties for Stimulants 5.5 Hallucinogens Natural Hallucinogens Semi-Synthetic Hallucinogens Synthetic Hallucinogens Legal Classification and Penalties for Hallucinogens 5.6 Cannabis (Marijuana) Legal Classification and Penalties for Cannabis 5.7 Psychotherapeutic Agents and Performance-Enhancing Drugs Psychotherapeutic Agents Performance-Enhancing Drugs Legal Classification and Penalties for Psychotherapeutic Agents and Performance-Enhancing Drugs 5.8 The Problem with Drug Effects and Legal Classifications Chapter 6:: The Socially Constructed Problem of Drugs and Drug Users 6.1 Bath Salts 6.2 Ecstasy 6.3 Crystal Meth 6.4 Cocaine 6.5 Prescription Stimulants:: Attention-Enhancing Prescription Drugs 6.6 Cannabis 6.7 Solvents/Inhalants 6.8 Prescription Opioids 6.9 Heroin 6.10 Hallucinogens 6.11 Bringing Together the Objective and Subjective Realities Chapter 7:: Studying Substance Use 7.1 Population-based Studies International Studies National Studies Provincial/Regional Studies Advantages and Disadvantages of Population-based Studies 7.2 Field-based Studies In-Depth Interviews Ethnographies Advantages and Disadvantages of Field-based Studies 7.3 Clinical Population Studies Treatment Studies Correctional Populations Advantages and Disadvantages of Clinical Population Studies 7.4 Indigenous Methodological Approaches 7.5 Conclusion Chapter 8:: Demographic Correlates of Substance Use in Canada 8.1 General Prevalence Rates of Substance Use in Canada 8.2 Demographic Correlates Age Sex Ethnicity and Race Socioeconomic Status (SES) Geographic Location 8.3 Conclusion Chapter 9:: Relational Correlates of Substance Use in Canada:: Peers and Families 9.1 Peer Influences Perceived Peer Use versus Actual Peer Use Social Activities and Peers Selection of Peers Intimate Partners 9.2 Families Sibling Influence Parental Influences Parental Substance Use 9.3 Conclusion Chapter 10:: Prevention Strategies for Drugs and Potential Drug Users in Education 10.1 Types of Prevention in Education Universal Prevention Selective Prevention Indicated Prevention 10.2 Drug Education in Schools 10.3 Models of Drug Education Information/Knowledge Models Values/Decision-Making Models Social Competency Models Harm Minimization/Harm Reduction Models 10.4 Drug Educators:: Teachers and Police 10.5 Ontario:: The Case of Failed Drug Education 10.6 Future of Drug Education:: The Good and the Bad Chapter 11:: Legal Responses to Drugs and Drug Users 11.1 Prohibition Advantages and Disadvantages of Prohibition 11.2 Decriminalization Advantages and Disadvantages of Decriminalization 11.3 Legalization Free-Market Legalization Limited-Distribution Legalization Medical Legalization Advantages and Disadvantages of Legalization 11.4 Conclusion Chapter 12:: International Drug Policies 12.1 International Drug Conventions 12.2 Punitive Policies Russia China Iran 12.3 Pragmatic Policies Portugal Netherlands Uruguay 12.4 Conclusion Chapter 13:: Canada’s Drug Policies 13.1 Advocates for Punitive Approaches 13.2 Advocates for Pragmatic Approaches 13.3 What is the Official Approach to Drugs and Drug Use in Canada? 13.4 The Missing Component in Canada’s Current National Anti-Drug Strategy:: Harm Reduction 13.5 The Future References
Komentarze (0)

  • Często kupowane razem

    Brak dostępnych produktów